The German pharmaceutical company BioNTech and its American partner Pfizer have begun developing a COVID-19 vaccine customized to the omicron coronavirus strain, for subsequent commercial usage. According to BioNTech CEO Ugura Sahina, the manufacture of a COVID-19 vaccine customized to the omicron version has begun. Clinical studies on the vaccine will begin in late January. After…
BioNTech has announced the establishment of a regional headquarters in Southeast Asia in Singapore. A fully integrated mRNA production facility is also to be established there with the support of the Singapore Economic Development Board. Vaccine production accelerates BioNTech plans to open an office in Singapore and begin construction of a manufacturing facility in 2021,…
Thanks to the adoption by the Committee for Medicines for Human (CHMP) belonging to the European Medicines Agency (EMA), two recommendations in April 2021 will increase the production capacity and supply of each of the companies producing vaccines against COVID-19. We are talking about the Pfizer/BioNTech and Moderna. Acceleration of production and a new production…
On Monday, Pfizer and BioNTech reported that the COVID-19 vaccine they are working on is over 90% effective. At that time, the world was overwhelmed with enthusiasm. On Wednesday, the EC signed an agreement with these companies to purchase 300 million doses of vaccine. So can we expect the pandemic to end soon? Pfizer and…
The U.S. pharmaceutical company Pfizer announced in a statement that the first test of COVID-19 vaccine developed in cooperation with the German biotechnology company BioNTech has been completed. Currently, there are four types of Pfizer vaccine for Sars-Cov-2 in the testing phase. One of them will be commercially available. World: ongoing work on COVID-19 vaccine…
The Ministry of Health explained that the decreasing number of those vaccinated with the third dose, in the daily statistics on COVID-19 vaccinations, is related to the correction of vaccination cards by the vaccination points. It has been discovered that booster injections are entered as the “third dose” instead of booster. Specifically, as the ministry communicated: “Despite the information…
The effectiveness statistics for Pfizer’s oral COVID-19 medicine are now so promising that the Big Pharma giant is ramping up production even before the FDA issues an emergency use license. Paxlovid will now be produced in the amount of 80 million courses by the end of 2022 an increase from the originally planned 50 million…
On November 2, registration for the COVID-19 booster vaccination for adults began, provided it has been at least six months since receiving the full vaccination. As of mid-September, only people over the age of 50, medical personnel in contact with patients, and people who are immunocompromised could make appointments for the booster vaccination. The booster shot…
New variants of Covid-19 mean that scientists are constantly looking for solutions to effectively protect as many people as possible from serious complications when infected with the virus. BioNTech’s CEO has announced that a new vaccine formulation needs to be developed to protect more effectively against new mutations of the disease, which are likely to…
The idea is controversial, but there are many indications that such a scenario is feasible. There are also many voices claiming that the government wants to encourage people delaying the COVID-19 vaccination to get vaccinated as soon as possible. This is because currently 16.97 million people in Poland have been vaccinated, 80% of whom are…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.